Last reviewed · How we verify
Anaplastic lymphoma kinase positive anaplastic large cell lymphoma
Approved treatments
- Alecensa · Hoffmann-La Roche
Alecensa blocks the activity of the ALK protein, which is involved in the growth and spread of cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Anaplastic lymphoma kinase positive anaplastic large cell lymphoma patent landscape — cliff calendar, originator estates, attackable patents
- Anaplastic lymphoma kinase positive anaplastic large cell lymphoma treatment landscape brief
- Anaplastic lymphoma kinase positive anaplastic large cell lymphoma treatment updates RSS
Frequently asked questions about Anaplastic lymphoma kinase positive anaplastic large cell lymphoma
What drugs treat Anaplastic lymphoma kinase positive anaplastic large cell lymphoma?
Tracked treatments include Alecensa.
What is the treatment for Anaplastic lymphoma kinase positive anaplastic large cell lymphoma?
Standard treatment for Anaplastic lymphoma kinase positive anaplastic large cell lymphoma includes Alecensa. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Anaplastic lymphoma kinase positive anaplastic large cell lymphoma patent cliff · Anaplastic lymphoma kinase positive anaplastic large cell lymphoma CI report
- Treatment: Alecensa · Hoffmann-La Roche
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing